Usana Health Sciences Inc
USNA- Exchange
- NYSE
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0000896264
No open-market purchases or sales by Usana Health Sciences Inc insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $243.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Usana Health Sciences Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 154 | 1 | 147 | −6 |
| Shares | 10.2M | 1.77M | 10.6M | +2.17M (+25.7%) |
| Value | $463.0M | $80.1M | $403.3M | +$20.4M (+5.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Usana Health Sciences Inc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,809,932 | $68.6M | 0.00% |
| Numerai GP LLC | 67,732 | $2.57M | 0.68% |
| Unison Advisors LLC | 18,000 | $682.6K | 0.08% |
| Creative Planning | 10,398 | $394.3K | 0.00% |
| Ethic Inc. | 5,427 | $263.2K | 0.01% |
| Quest Partners LLC | 6,603 | $250.4K | 0.02% |
| Centiva Capital, LP | 5,606 | $212.6K | 0.01% |
| Shell Asset Management Co | 2,062 | $78.0K | 0.00% |
| Headlands Technologies LLC | 956 | $36.3K | 0.00% |
| Safe Harbor Fiduciary, LLC | 800 | $30.3K | 0.03% |
| Continuum Advisory, LLC | 190 | $7.49K | 0.00% |
| Venturi Wealth Management, LLC | 110 | $4.17K | 0.00% |
| Sterling Capital Management LLC | 40 | $1.52K | 0.00% |
| Private Wealth Management Group, LLC | 28 | $1.06K | 0.00% |
| Aster Capital Management (DIFC) Ltd | 3 | $114 | 0.00% |
| Mendota Financial Group, LLC | 2 | $76 | 0.00% |
| Capital Performance Advisors LLP | 1 | $38 | 0.00% |
Sold out (23)
Institutions that held Usana Health Sciences Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| SEI Investments Co | 18,728 | $847.3K |
| Acadian Asset Management LLC | 18,360 | $830.0K |
| Cubist Systematic Strategies, LLC | 11,822 | $534.8K |
| Marshall Wace, LLP | 11,602 | $524.9K |
| Guggenheim Capital LLC | 10,533 | $476.5K |
| Cornercap Investment Counsel Inc | 10,413 | $471.1K |
| SG Americas Securities, LLC | 7,522 | $340.0K |
| Campbell & CO Investment Adviser LLC | 6,170 | $279.1K |
| Summit Global Investments | 6,049 | $274.0K |
| Millennium Management LLC | 4,827 | $218.4K |
| Manufacturers Life Insurance Company, The | 4,610 | $208.6K |
| Yousif Capital Management, LLC | 4,500 | $203.6K |
| EntryPoint Capital, LLC | 2,565 | $116.0K |
| Qube Research & Technologies Ltd | 1,672 | $75.6K |
| Point72 Asia (Singapore) Pte. Ltd. | 271 | $12.2K |
| Bessemer Group Inc | 124 | $6.00K |
| Ronald Blue Trust, Inc. | 110 | $5.33K |
| Innealta Capital, LLC | 41 | $1.85K |
| Huntington National Bank | 30 | $1.36K |
| Capital Advisors, Ltd. LLC | 18 | $1.00K |
| IFP Advisors, Inc | 15 | $679 |
| Abound Wealth Management | 6 | $272 |
| Avion Wealth | 11 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Usana Health Sciences Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,770,198 | $80.1M |